ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026

Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study.

Minjiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.